Join the 'Brain Tumor' group to help and get support from people like you.

Brain Tumor Blog

Related terms: Brain Cancer, Brain Tumor, metastatic, Cancer, Brain, Intracranial Tumors

Aspirin Might Help Treat Brain Tumor Tied to Hearing Loss

Posted 30 Jan 2014 by Drugs.com

THURSDAY, Jan. 30, 2014 – Aspirin might slow the growth of a noncancerous type of brain tumor that can lead to hearing loss, ringing in the ears (tinnitus) and even death, according to new research. For the study, which was published in the February issue of the journal Otology and Neurotology, researchers examined data from nearly 700 people who were diagnosed with vestibular schwannomas (also called acoustic neuromas). There is no approved medication to treat these tumors, which grow on the nerves that connect the brain to the ears, the researchers said. Current treatment options include surgery or radiation therapy, both of which can cause serious complications, the researchers said. Their analysis revealed that the rate of tumor growth was slower in patients who took aspirin than in those who didn't take the drug. Age and gender did not affect the findings. "Our results suggest a ... Read more

Related support groups: Aspirin, Tinnitus, Brain Tumor, Ecotrin, Bayer Aspirin, Bufferin, Low Dose ASA, Aspergum, Buffered Aspirin, Ascriptin Enteric, Easprin, St Joseph Aspirin, ZORprin, Sloprin, Bayer Plus, Genprin, Aspirin Lite Coat, Empirin, Stanback Analgesic, Litecoat Aspirin

Modified Polio Virus May Help Fight Brain Tumors, Study Suggests

Posted 23 May 2013 by Drugs.com

THURSDAY, May 23 – A modified version of the polio virus might one day help fight brain tumors, preliminary research suggests. Scientists at Duke Cancer Institute said the investigational therapy, known as PVSRIPO, uses an engineered form of the virus that is harmless to normal cells, but attacks cancer cells. The therapy shows promise in the treatment of glioblastoma, the most common and aggressive brain tumor, they said. "These early results are intriguing," principal investigator Dr. Annick Desjardins, an associate professor of medicine at Duke University School of Medicine, said in a news release. "Current therapies for glioblastoma are limited because they cannot cross the blood-brain barrier and often do not specifically attack the tumor. This treatment appears to overcome those problems." The findings are scheduled for presentation at the American Society of Clinical Oncology ... Read more

Related support groups: Brain Tumor, Poliomyelitis Prophylaxis

Gauging Brain Cancer Survival Time May Get Easier: Study

Posted 10 Apr 2013 by Drugs.com

WEDNESDAY, April 10 – Life expectancy of people with aggressive brain cancer may be easier to determine with a new method under development at the University of Alabama at Birmingham, researchers say. The UAB researchers found that patients with an overactive version of a specific enzyme live less than half as long as those with a less active version. This overactive enzyme can help predict how resistant the brain cancer will be to chemotherapy, and also help doctors arrive at treatment recommendations, the researchers said. In conducting the study, published April 10 in the journal PLoS ONE, the researchers examined tumors from 84 patients with a form of brain cancer known as glioblastoma multiforme (GBM). This deadly and aggressive cancer quickly becomes resistant to available treatments. With a combination of surgery, radiation and the chemotherapy drug temozolomide, patients with ... Read more

Related support groups: Brain Tumor, Glioblastoma Multiforme, Malignant Glioma, Anaplastic Oligodendroglioma, Angioblastoma, Anaplastic Astrocytoma

Brain Surgery Eases Compulsive Eating in 10-Year-Old Girl

Posted 9 Apr 2013 by Drugs.com

TUESDAY, April 9 – Removal of a rare type of benign brain tumor helped bring a young girl's compulsive eating under control, doctors report. The 10-year-old had what's known as a hypothalamic hamartoma – a tumor in or around the brain's hypothalamus. One of the symptoms of this type of tumor is extremely early (precocious) puberty, as well as compulsive eating and excessive weight gain. As reported online April 9 in the Journal of Neurosurgery: Pediatrics, by age 10 the girl already weighed 227 pounds and was gaining an average of five more pounds each month. Medication and counseling did nothing to curb her overeating. Despite the fact that there was no record of it having been done before, neurosurgeons at the University of Texas-Houston and Children's Memorial Hermann Hospital in Houston decided to remove the girl's hypothalamic hamartoma in an effort to curb her overeating. The ... Read more

Related support groups: Eating Disorder, Brain Tumor

Scientists Link More Genes to Common Brain Tumor

Posted 24 Jan 2013 by Drugs.com

THURSDAY, Jan. 24 – Abnormalities in just five genes account for the majority of meningioma brain tumors, according to a new study. Meningiomas are the most common type of brain tumor. They are usually benign but are cancerous in about 10 percent of cases. Surgery is the only treatment for meningiomas, but this finding could help lead to new therapies tailored to individual patients, according to the study authors. Previous research found that about half of meningiomas were linked to a mutation or deletion of a gene called neurofibromin 2. The genetic origin of the other types of meningiomas was unknown. In this study, researchers analyzed samples from 300 meningiomas and found that abnormalities in four other genes are also linked to the brain tumors. Each of these genes tends to be associated with tumors in different areas of the brain. Location can indicate how likely meningiomas ... Read more

Related support groups: Brain Tumor

New Raccoon Virus May Offer Clues to Human Cancer

Posted 28 Dec 2012 by Drugs.com

FRIDAY, Dec. 28 – Rare brain tumors found in raccoons in Northern California and Oregon may be linked to a new virus, according to a new study. Researchers, led by scientists from the University of California, Davis, said their findings could shed light on how viruses cause cancer in both animals and humans. "Understanding how infectious agents may contribute to cancer in animals has provided fundamental new knowledge on the cause of cancer in people," Michael Lairmore, dean of the university's School of Veterinary Medicine, said in a university news release. Autopsies performed on raccoons beginning in March 2010 revealed 10 raccoons had brain tumors. Of these raccoons, nine were from Northern California. The additional raccoon was sent to the university by researchers at Oregon State University. All of the tumors found in these raccoons had a new virus, known as raccoon polyomavirus. ... Read more

Related support groups: Cancer, Brain Tumor

FDA Approves Afinitor Disperz - First Drug Formulated for Children with Rare Brain Tumor

Posted 29 Aug 2012 by Drugs.com

The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA). Afinitor Disperz is the first approved pediatric-specific dosage form developed for the treatment of a pediatric tumor. Afinitor Disperz is recommended to treat patients ages 1 year and older with tuberous sclerosis complex (TSC) who are diagnosed with SEGA that cannot be treated with surgery. Prior to approval of this new dosage form, Afinitor was recommended for use only in patients ages 3 years old and older. Afinitor was granted accelerated approval in 2010 to treat SEGA in patients with TSC. “Appropriate pediatric dosage forms, such as Afinitor Disperz, help to ensure the safe and effective use of oncology drugs in ... Read more

Related support groups: Brain Tumor, Afinitor, Everolimus

Gene Might Predict Brain Tumors' Aggressiveness

Posted 27 Aug 2012 by Drugs.com

MONDAY, Aug. 27 – A gene variant that increases the risk of certain types of brain tumors has been identified by U.S. researchers, who say their findings could help identify people at risk of developing these tumors and improve their treatment. The team found that people who carry a "G" instead of an "A" at a specific location in their genetic code have about a sixfold increased risk of developing certain subtypes of gliomas, which account for about 20 percent of brain cancers diagnosed in the United States. The study was published online Aug. 26 in the journal Nature Genetics. The researchers said they still have to confirm whether this location in the genetic code is the source of tumors. Even if it's not, "it is pretty close," study senior author Dr. Robert Jenkins, a pathologist at the Mayo Clinic Cancer Center in Rochester, Minn., said in a Mayo news release. "Based on our ... Read more

Related support groups: Brain Tumor

Multiple Brain Tumors Even More Malignant: Study

Posted 26 Aug 2012 by Drugs.com

FRIDAY, Aug. 24 – Patients with aggressive malignant brain tumors in multiple locations live a much shorter time than those with a single brain tumor, even though both groups of patients receive virtually identical treatments, according to a new study. Researchers from Cedars-Sinai Medical Center in West Hollywood, Calif., compared the outcomes of 47 patients with multiple glioblastoma multiforme brain tumors and 47 patients with a single tumor. Average survival was six months for those with multiple tumors and 11 months for those with one tumor. A large number of tumors in the patients with multiple tumors appeared to be resistant to treatment and continued to grow even after patients underwent radiation therapy, noted study first author Dr. Chirag Patil, director of the Center for Neurosurgical Outcomes Research at Cedars-Sinai. The study was published Aug. 24 in the Journal of ... Read more

Related support groups: Brain Tumor

18 Million U.S. Cancer Survivors Expected by 2022: Report

Posted 14 Jun 2012 by Drugs.com

THURSDAY, June 14 – There are now more than 13 million cancer survivors living in the United States and that number is expected to reach 18 million in just 10 years, a new report predicts. This dramatic increase will be driven, in large part, by a combination of earlier diagnosis and better treatment of some of the most common cancers, according to the report from the American Cancer Society and the U.S. National Cancer Institute. "We are focusing on the number of people who are now alive who have experienced cancer at some time in the past, and their transition from treatment to recovery and the balance of their life," said report co-author Elizabeth Ward, national vice president of intramural research at the American Cancer Society. More people are surviving cancer because the number of people diagnosed with cancer is rising and because the size of this population, particularly older ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Skin Cancer, Bladder Cancer, Cervical Cancer, Head and Neck Cancer, Gastric Cancer, Solid Tumors

Child CT Scans Might Up Risk of Brain Cancer, Leukemia

Posted 7 Jun 2012 by Drugs.com

WEDNESDAY, June 6 – Children who undergo CT scans of the head may raise their risk of developing brain cancer or leukemia later in life, a new study says. Although multiple CT scans could triple the risk, the absolute risk remains small – one case in 10,000 scans of the head, the researchers said. "We have shown small increased risks associated with the radiation exposures from CT," said study co-author Louise Parker, from the Canadian Cancer Society and a professor of medicine and pediatrics at Dalhousie University in Halifax, Nova Scotia. "As long as CT is used only where justified, then the benefits of CT, a potentially lifesaving modality, will almost certainly outweigh the risks," she said. Lead study author Amy Berrington de Gonzalez, from the U.S. National Cancer Institute, said this study is the first to look at the actual cancer risk of radiation from CT scans. "All the ... Read more

Related support groups: Leukemia, Brain Tumor, Diagnosis and Investigation

Brain Tumor Vaccine Shows Promise in Early Trial

Posted 17 Apr 2012 by Drugs.com

TUESDAY, April 17 – A vaccine made from brain cancer patients' own tumor cells led to a nearly 50 percent improvement in survival times for those stricken with glioblastoma multiforme, the same malignancy that claimed the life of U.S. Sen. Edward Kennedy, a new study suggests. A phase 2 multicenter trial of about 40 patients with recurrent glioblastoma – an aggressive brain cancer that typically kills patients within 15 months of diagnosis – showed that the vaccine safely increased average survival to nearly 48 weeks, compared with about 33 weeks among patients who didn't receive the treatment. The six-month survival rate was 93 percent for the vaccinated group, compared with 68 percent for 86 other glioblastoma patients, who were treated with other therapies. "We've done a lot of things for this kind of tumor in the last 40 or 50 years, all variations on different chemotherapies ... Read more

Related support groups: Brain Tumor, Glioblastoma Multiforme

Study Suggests Vaccine May Help Kids With Brain Cancer

Posted 3 Apr 2012 by Drugs.com

TUESDAY, April 3 – A vaccination may help boost the immune system of children with brain tumors, a small new study reports. The prognosis for many children with brain tumors, known as gliomas, is grim. Radiation is the only effective treatment, although there has been hope that a vaccine could boost the immune system's response. The results of the new study, which included 27 children and was funded by the U.S. National Institutes of Health, were released Monday at the annual meeting of the American Association for Cancer Research (AACR) in Chicago. "We've found that the vaccine is tolerated well with limited systemic toxicity, but we've also observed that there are some patients who have immunological responses to the vaccine target in the brain that can cause swelling and transient worsening, and subsequently, some of those children can have very favorable responses," study lead ... Read more

Related support groups: Brain Tumor, Malignant Glioma, Anaplastic Oligodendroglioma

New Technique to Remove Skull Tumors May Mean Less Scarring

Posted 1 Nov 2011 by Drugs.com

TUESDAY, Nov. 1 – A new surgical method that uses a natural opening to remove skull base tumors results in fewer complications, less scarring and faster recovery for patients, according to the surgeons who developed the technique. The natural opening used in this type of procedure is located behind the molars, above the jawbone and beneath the cheekbone. Traditional surgeries to remove skull base tumors require incisions through the face and bone removal. These procedures can be disfiguring, cause nerve damage that results in facial paralysis, and require days or weeks of hospitalization and recovery. The new approach developed by Johns Hopkins University School of Medicine surgeons was first performed on a patient last year. Surgery time was reduced from six hours to two hours, the patient was discharged from the hospital the next day and had no visible evidence of the surgery. Since ... Read more

Related support groups: Surgery, Brain Tumor

Cancer Patients Should Ask Doctors to Use Simple Terms

Posted 28 Sep 2011 by Drugs.com

WEDNESDAY, Sept. 28 – Cancer patients are often faced with many difficult-to-understand treatment choices that can have serious side effects and even mean the difference between life and death. That's why it's crucial that patients insist doctors use plain language in explaining the options, advised Angela Fagerlin, an associate professor of internal medicine at the University of Michigan Medical School and a researcher at the U-M Comprehensive Cancer Center. "People are making life and death decisions that may affect their survival and they need to know what they're getting themselves into. Cancer treatments and tests can be serious. Patients need to know what kind of side effects they might experience as a result of the treatment they undergo," Fagerlin said in a university news release. She and her colleagues outlined a number of tips to help patients get the information they need ... Read more

Related support groups: Cancer, Provera, Methotrexate, Depo-Provera, Breast Cancer, Lupron, Accutane, Prostate Cancer, Tamoxifen, Medroxyprogesterone, Arimidex, Lupron Depot, Femara, Gleevec, Fluorouracil, Renal Cell Carcinoma, Lung Cancer, Zoladex, Claravis, Rituxan

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Glioblastoma Multiforme, Pituitary Tumor, Anaplastic Oligodendroglioma, Anaplastic Astrocytoma, Malignant Glioma, Angioblastoma, Cancer

Related Drug Support Groups

methotrexate, Afinitor, cisplatin, cyclophosphamide, everolimus, Platinol, Zortress, lomustine, Platinol-AQ, BiCNU, carmustine, Gliadel, CeeNU